FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2101716002> ?p ?o ?g. }

• W2101716002 endingPage "360" @default.
• W2101716002 startingPage "353" @default.
• W2101716002 abstract "Background: Immunosuppressive treatment initiated at an early stage in patients with idiopathic membranous nephropathy (iMN) improves renal survival. Treatment should ideally be restricted to high-risk patients. Aim: To evaluate the efficacy of a restrictive immunosuppressive treatment strategy for patients with iMN. Design: Prospective cohort study evaluating a predefined treatment protocol. Methods: From 1988, we adopted a restrictive treatment strategy: immunosuppressive treatment, mainly consisting of cyclophosphamide and steroids, was advised only in patients with renal insufficiency or severe intolerable nephrotic syndrome. We evaluated this strategy in a large patient cohort. To exclude any bias, we included all adult patients with iMN biopsied in the study period with a serum creatinine (Scr) < 135 μmol/l, a proteinuria ≥ 3.0 g/day and/or a serum albumin (Salb) ≤ 30 g/l at the time of biopsy. Analysis was according to the intention-to-treat principle. Results: We studied 69 patients. At the time of biopsy, mean age was 51 years, Scr 90 μmol/l, Salb 23 g/l and proteinuria 6.7 g/day. Average follow-up was 5.5 years. Thus far 33 (48%) patients have received immunosuppressive therapy, mainly because of renal insufficiency (n = 24). Status at the end of follow-up was: complete remission n = 22 (32%), partial remission n = 24 (35%), nephrotic syndrome n = 15 (22%), persistent proteinuria n = 1 (1.4%), ESRD n = 6 (8.7%), death n = 1 (1.4%; due to bladder carcinoma after cyclophosphamide therapy). Patient survival was 100% at 5 and 7 years. Renal survival was 94% at 5 years and 88% at 7 years. Discussion: In patients with iMN, a restrictive treatment policy assures a favourable prognosis, while preventing exposure to immunosuppressive therapy in >50% of the patients." @default.
• W2101716002 created "2016-06-24" @default.
• W2101716002 creator A5015051666 @default.
• W2101716002 creator A5034633952 @default.
• W2101716002 creator A5035395189 @default.
• W2101716002 creator A5035441879 @default.
• W2101716002 creator A5039896011 @default.
• W2101716002 creator A5074269391 @default.
• W2101716002 creator A5023124249 @default.
• W2101716002 date "2004-05-19" @default.
• W2101716002 modified "2023-09-27" @default.
• W2101716002 title "Restrictive use of immunosuppressive treatment in patients with idiopathic membranous nephropathy: high renal survival in a large patient cohort" @default.
• W2101716002 cites W1550111394 @default.
• W2101716002 cites W1982367409 @default.
• W2101716002 cites W1984702041 @default.
• W2101716002 cites W1990358842 @default.
• W2101716002 cites W1996141686 @default.
• W2101716002 cites W2020987938 @default.
• W2101716002 cites W2023720190 @default.
• W2101716002 cites W2034759249 @default.
• W2101716002 cites W2051702141 @default.
• W2101716002 cites W2067857277 @default.
• W2101716002 cites W2073033781 @default.
• W2101716002 cites W2077780912 @default.
• W2101716002 cites W2080808920 @default.
• W2101716002 cites W2094462520 @default.
• W2101716002 cites W2097201764 @default.
• W2101716002 cites W2115472834 @default.
• W2101716002 cites W2143263078 @default.
• W2101716002 cites W2146020479 @default.
• W2101716002 cites W2153652747 @default.
• W2101716002 cites W2260911688 @default.
• W2101716002 cites W4245487764 @default.
• W2101716002 cites W4255817401 @default.
• W2101716002 cites W4256022872 @default.
• W2101716002 cites W2025622503 @default.
• W2101716002 doi "https://doi.org/10.1093/qjmed/hch059" @default.
• W2101716002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15152109" @default.
• W2101716002 hasPublicationYear "2004" @default.
• W2101716002 type Work @default.
• W2101716002 sameAs 2101716002 @default.
• W2101716002 citedByCount "22" @default.
• W2101716002 countsByYear W21017160022012 @default.
• W2101716002 countsByYear W21017160022013 @default.
• W2101716002 countsByYear W21017160022014 @default.
• W2101716002 countsByYear W21017160022015 @default.
• W2101716002 countsByYear W21017160022016 @default.
• W2101716002 countsByYear W21017160022017 @default.
• W2101716002 countsByYear W21017160022020 @default.
• W2101716002 crossrefType "journal-article" @default.
• W2101716002 hasAuthorship W2101716002A5015051666 @default.
• W2101716002 hasAuthorship W2101716002A5023124249 @default.
• W2101716002 hasAuthorship W2101716002A5034633952 @default.
• W2101716002 hasAuthorship W2101716002A5035395189 @default.
• W2101716002 hasAuthorship W2101716002A5035441879 @default.
• W2101716002 hasAuthorship W2101716002A5039896011 @default.
• W2101716002 hasAuthorship W2101716002A5074269391 @default.
• W2101716002 hasBestOaLocation W21017160021 @default.
• W2101716002 hasConcept C126322002 @default.
• W2101716002 hasConcept C126894567 @default.
• W2101716002 hasConcept C141071460 @default.
• W2101716002 hasConcept C2775934546 @default.
• W2101716002 hasConcept C2775946357 @default.
• W2101716002 hasConcept C2776694085 @default.
• W2101716002 hasConcept C2776755627 @default.
• W2101716002 hasConcept C2778930706 @default.
• W2101716002 hasConcept C2779561371 @default.
• W2101716002 hasConcept C2780091579 @default.
• W2101716002 hasConcept C2780306776 @default.
• W2101716002 hasConcept C2781087799 @default.
• W2101716002 hasConcept C71924100 @default.
• W2101716002 hasConcept C72563966 @default.
• W2101716002 hasConcept C90924648 @default.
• W2101716002 hasConceptScore W2101716002C126322002 @default.
• W2101716002 hasConceptScore W2101716002C126894567 @default.
• W2101716002 hasConceptScore W2101716002C141071460 @default.
• W2101716002 hasConceptScore W2101716002C2775934546 @default.
• W2101716002 hasConceptScore W2101716002C2775946357 @default.
• W2101716002 hasConceptScore W2101716002C2776694085 @default.
• W2101716002 hasConceptScore W2101716002C2776755627 @default.
• W2101716002 hasConceptScore W2101716002C2778930706 @default.
• W2101716002 hasConceptScore W2101716002C2779561371 @default.
• W2101716002 hasConceptScore W2101716002C2780091579 @default.
• W2101716002 hasConceptScore W2101716002C2780306776 @default.
• W2101716002 hasConceptScore W2101716002C2781087799 @default.
• W2101716002 hasConceptScore W2101716002C71924100 @default.
• W2101716002 hasConceptScore W2101716002C72563966 @default.
• W2101716002 hasConceptScore W2101716002C90924648 @default.
• W2101716002 hasIssue "6" @default.
• W2101716002 hasLocation W21017160021 @default.
• W2101716002 hasLocation W21017160022 @default.
• W2101716002 hasOpenAccess W2101716002 @default.
• W2101716002 hasPrimaryLocation W21017160021 @default.
• W2101716002 hasRelatedWork W1985654865 @default.
• W2101716002 hasRelatedWork W2018433810 @default.
• W2101716002 hasRelatedWork W2082674992 @default.
• W2101716002 hasRelatedWork W2146598123 @default.
• W2101716002 hasRelatedWork W2255097837 @default.

• next